These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30957162)

  • 41. [The role of the variability of gonococci in the development of therapeutic-prophylactic measures in gonorrhea].
    Mavrov II; Gorisiuk AF
    Mikrobiol Zh (1978); 1987; 49(4):62-4. PubMed ID: 3150499
    [No Abstract]   [Full Text] [Related]  

  • 42. Gonococcal drug resistance and treatment of gonorrhoea in Nairobi.
    Perine PL; Biddle JW; Nsanze H; D'Costa LJ; Osaba AO; Widy-Wirski R
    East Afr Med J; 1980 Apr; 57(4):238-46. PubMed ID: 6771118
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Increasing antibiotic resistance in Neisseria gonorrhoeae].
    van Everdingen JJ; van Klingeren B; Stolz E
    Ned Tijdschr Geneeskd; 1986 Nov; 130(48):2166-8. PubMed ID: 3100967
    [No Abstract]   [Full Text] [Related]  

  • 44. Importation into the UK of a strain of Neisseria gonorrhoeae resistant to penicillin, ciprofloxacin and tetracycline.
    Turner A; Gough KR; Jephcott AE; McClean AN
    Genitourin Med; 1995 Oct; 71(5):331-2. PubMed ID: 7490059
    [No Abstract]   [Full Text] [Related]  

  • 45. Antimicrobial resistance patterns in
    Nacht C; Agingu W; Otieno F; Odhiambo F; Mehta SD
    Int J STD AIDS; 2020 Jan; 31(1):46-52. PubMed ID: 31870236
    [No Abstract]   [Full Text] [Related]  

  • 46. Gonococcal resistance can be viewed productively as part of a syndemic of antimicrobial resistance: an ecological analysis of 30 European countries.
    Kenyon C; Manoharan-Basil SS; Van Dijck C
    Antimicrob Resist Infect Control; 2020 Jun; 9(1):97. PubMed ID: 32605597
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The sensitivity of 173 Sydney isolates of Neisseria gonorrhoeae to cefpodoxime and other antibiotics used to treat gonorrhea.
    Tapsall JW; Phillips EA
    Pathology; 1995 Jan; 27(1):64-6. PubMed ID: 7603756
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The prevalence and antibiotics susceptibility pattern of Neisseria gonorrhoeae in patients attending OPD clinics at St. Mary's Hospital Lacor Uganda.
    Amito Florence P; Otim F; Okongo F; Ogwang M; Greco D
    J Prev Med Hyg; 2012 Dec; 53(4):186-9. PubMed ID: 23469585
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antimicrobial resistance in Neisseria gonorrhoeae and limited treatment options.
    Zafar A; Jabeen K
    J Pak Med Assoc; 2007 Jul; 57(7):333-4. PubMed ID: 17867252
    [No Abstract]   [Full Text] [Related]  

  • 50. Cephalosporin-resistant gonorrhea: it's just a matter of time.
    Deresinski S
    AIDS Alert; 2011 Oct; 26(10):115-6. PubMed ID: 22096785
    [No Abstract]   [Full Text] [Related]  

  • 51. Antimicrobial sensitivity of Neisseria gonorrhoeae: a hospital-based study from Kuwait.
    Sharma AK; Al-Mutairi N; Zaki A; Nour-Eldin O; Joshi A; Rijhwani M; Al-Tayeh MY; Sultan AM
    J Chemother; 2005 Feb; 17(1):117-8. PubMed ID: 15828455
    [No Abstract]   [Full Text] [Related]  

  • 52. Antibiotic resistance of Neisseria gonorrhoeae in Spain: trends over the last two decades.
    Arreaza L; Salcedo C; Alcalá B; Berrón S; Martín E; Vázquez JA
    J Antimicrob Chemother; 2003 Jan; 51(1):153-6. PubMed ID: 12493801
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antibiotic resistance in Neisseria gonorrhoeae is diminishing available treatment options for gonorrhea: some possible remedies.
    Tapsall J
    Expert Rev Anti Infect Ther; 2006 Aug; 4(4):619-28. PubMed ID: 17009941
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro susceptibility of Spanish isolates of Neisseria gonorrhoeae to cefditoren and five other antimicrobial agents.
    Vázquez JA; Martín E; Galarza P; Giménez MJ; Aguilar L; Coronel P
    Int J Antimicrob Agents; 2007 Apr; 29(4):473-4. PubMed ID: 17276040
    [No Abstract]   [Full Text] [Related]  

  • 55. Cephalosporin-Resistant Neisseria gonorrhoeae Isolated in Portugal, 2019.
    Pinto M; Matias R; Rodrigues JC; Duarte S; Vieira L; Gonçalves I; Gonçalves MJ; Ramos MH; Gomes JP; Borrego MJ
    Sex Transm Dis; 2020 Nov; 47(11):e54-e56. PubMed ID: 32530860
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combination therapy and the resistant gonococcus.
    Barlow D; Thin RN; Phillips I
    Lancet; 1983 Jan; 1(8316):125-6. PubMed ID: 6129438
    [No Abstract]   [Full Text] [Related]  

  • 57. Multidrug Resistance in Neisseria gonorrhoeae: Identification of Functionally Important Residues in the MtrD Efflux Protein.
    Chitsaz M; Booth L; Blyth MT; O'Mara ML; Brown MH
    mBio; 2019 Nov; 10(6):. PubMed ID: 31744915
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 2001. World Health Organization.
    Commun Dis Intell Q Rep; 2002; 26(4):541-5. PubMed ID: 12549520
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro antimicrobial susceptibilities of penicillinase-producing and non-penicillinase-producing strains of Neisseria gonorrhoeae isolated in Durban, South Africa.
    Coovadia YM; Ramsaroop U
    Antimicrob Agents Chemother; 1984 Nov; 26(5):770-2. PubMed ID: 6440480
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [E-test quantitative determination for evaluating Neisseria gonorrhoeae resistance].
    Filipiuc S; Iancu LS
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):1169-74. PubMed ID: 21500474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.